Stifel raised the firm’s price target on Exelixis (EXEL) to $44 from $43 and keeps a Hold rating on the shares following a Q4 report that held “no surprises” after management’s recent preannouncement of net product revenue, issuance of FY26 guidance, and provision of a comprehensive corporate update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXEL:
